文献速递胸部骨肌CT

软组织与骨肉瘤肺转移基线CT影像参数预测生存

Baseline CT imaging parameters predicting overall and progression-free survival for patients with pulmonary metastases from soft tissue and bone sarcoma.
PubMed 文献 · Eur Radiol · 2026-01-03

本研究回顾性纳入100例接受全身治疗的软组织与骨肉瘤肺转移患者,评估基线CT肺病灶数量与肿瘤负荷对总生存期(OS)和无进展生存期(PFS)的预测价值。结果显示肺病灶数量≥5个可独立预测较短OS,而肿瘤负荷参数对OS和PFS均无预测价值。

要点

  • 基线CT肺转移灶数量≥5个提示软组织与骨肉瘤患者OS较短。
  • 肺转移灶长径、体积等肿瘤负荷参数不预测OS或PFS。
  • 无影像参数可独立预测PFS,评估时避免过度解读。

核心结论

  • 基线CT肺转移灶数量≥5个可独立预测软组织与骨肉瘤患者较短的总生存期(HR 3.478,95% CI: 1.509-8.302,p = 0.004)。
  • 肺肿瘤负荷参数(长轴、体积)对OS和PFS均无预测价值(HR 0.724-1.354,p = 0.265-0.975)。
  • 无基线CT影像参数可独立预测无进展生存期。

研究设计与样本

  • 回顾性研究,连续筛查2016年至2021年接受治疗的软组织与骨肉瘤肺转移患者。
  • 纳入100例有全身治疗、基线CT且无既往肺部手术的肺转移患者。
  • 在基线CT上评估肺病灶长轴、体积及病灶数量。
  • 将单因素分析中有意义的预测因素纳入多因素模型,以风险比(HR)报告。

关键影像表现/征象

  • 基线CT肺转移灶数量≥5个在单因素分析中预测较短OS(HR 1.709,95% CI: 1.013-2.881,p = 0.033)。
  • 肺转移灶数量≥5个在多因素分析中仍独立预测较短OS(HR 3.478,95% CI: 1.509-8.302,p = 0.004)。
  • 肺转移灶数量≥5个在单因素分析中预测较短PFS(HR 1.741,95% CI: 1.113-2.723,p = 0.011),但多因素分析中不再显著(HR 1.530,95% CI: 0.395-7.391,p = 0.555)。

诊断标准与关键数值

  • 肺转移灶数量≥5个作为阈值,多因素分析显示其预测较短OS的HR为3.478(95% CI: 1.509-8.302,p = 0.004)。
  • 肺肿瘤负荷参数(长轴、体积)的HR范围为0.724-1.354,p值为0.265-0.975,均无统计学意义。

临床应用与阅片要点

  • 阅片报告软组织与骨肉瘤肺转移时,应明确描述肺转移灶数量,尤其是是否达到5个及以上。
  • 肺转移灶数量≥5个可作为预后提示信息,有助于临床制定治疗决策。
  • 肿瘤负荷参数(长径、体积)对生存无预测价值,报告中不必将其作为预后指标强调。

局限性

  • 本研究为回顾性设计,存在选择偏倚的可能。
  • 仅纳入单中心连续患者,样本量相对有限。
  • 研究人群限于接受全身治疗且无既往肺部手术的患者,结论外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The lung is the most frequent metastatic site in soft tissue and bone sarcoma, yet CT imaging predictors of survival remain underexplored. Hence, the aim of this study was to evaluate baseline CT imaging predictors for overall survival (OS) and progression-free survival (PFS) in patients with pulmonary metastases from soft tissue and bone sarcoma.

MATERIALS AND METHODS: Consecutive patients treated from 2016 to 2021 were screened; those without lung metastases, systemic therapy, baseline CT imaging, or with prior lung surgery were excluded. Tumor burden (long axis, volume) and number of pulmonary lesions were assessed at baseline CT imaging and tested for OS and PFS. Significant univariate predictors were entered into multivariate models and reported as hazard ratios (HR).

RESULTS: In the 100 included patients, median OS was 22.1 months, and median PFS was 5.8 months. Tumor burden parameters were not predictive of OS nor PFS (HR 0.724-1.354, p = 0.265-0.975). The number of pulmonary lesions was prognostic, with ≥ 5 lesions predicting shorter OS in univariate (HR 1.709, 95% CI: 1.013-2.881, p = 0.033) and multivariate analysis (HR 3.478, 95% CI: 1.509-8.302, p = 0.004). For PFS, ≥ 5 lesions were significant in univariate analysis (HR 1.741, 95% CI: 1.113-2.723, p = 0.011) but not in multivariate analysis (HR 1.530, 95% CI: 0.395-7.391, p = 0.555).

CONCLUSION: At baseline, CT imaging of patients with soft tissue and bone sarcoma, the number of pulmonary lesions independently predicted OS, whereas tumor burden showed no prognostic value. No imaging parameter independently predicted PFS.

KEY POINTS: Question Which baseline CT imaging parameters best predict overall and PFS in patients with pulmonary metastases from soft tissue and bone sarcoma? Findings At baseline, CT imaging, pulmonary lesion count independently predicted OS, while pulmonary tumor burden was not prognostic. No imaging parameter independently predicted PFS. Clinical relevance Baseline CT imaging assessment of the number of pulmonary lesions provides prognostic information and may inform treatment decisions in patients with soft tissue and bone sarcoma.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Klambauer, Gold, Klinge, et al. Baseline CT imaging parameters predicting overall and progression-free survival for patients with pulmonary metastases from soft tissue and bone sarcoma. Eur Radiol. 2026. PMID: 41483204. doi:10.1007/s00330-025-12289-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。